| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/09/1992 | US5120639 Neutralizing herpes simplex virus DNA polymerase using an antibody obtained from a specified decapeptide and measuring amount of bound antibody |
| 06/09/1992 | US5120536 Pure cultures from which crystalline parasporal proteins are obtained |
| 06/09/1992 | US5120535 Synergistic mixture with interferons |
| 06/09/1992 | US5120534 Administering at least one polypeptide from interleukin and derivatives |
| 06/09/1992 | CA1303292C Anhydrous enhanced coupling |
| 06/09/1992 | CA1303030C Glycosyl derivatives and use thereof |
| 06/09/1992 | CA1303009C Substrates with sterically-protected, stable, covalently-bonded organo-silane films |
| 06/09/1992 | CA1302925C Liquid detergents containing surfactant, proteolytic enzyme and boric acid |
| 06/09/1992 | CA1302924C Liquid detergents containing anionic surfactant, builder and proteolytic enzyme |
| 06/09/1992 | CA1302921C Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin |
| 06/09/1992 | CA1302883C Method of preparing toxoid |
| 06/09/1992 | CA1302882C Vaccines and immunoglobulin g-containing preparations active against pseudomonas aeruginosa |
| 06/09/1992 | CA1302878C Agent for the regulation of the appetite or a sleeping agent |
| 06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/08/1992 | WO1992010572A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/08/1992 | WO1992010571A1 Human dopamine d4 receptor and its uses |
| 06/08/1992 | CA2097509A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
| 06/07/1992 | WO1992010205A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | WO1992010092A1 Very large scale immobilized polymer synthesis |
| 06/07/1992 | CA2097825A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 06/07/1992 | CA2097708A1 Very large scale immobilized polymer synthesis |
| 06/05/1992 | WO1992010562A1 Ganoderma lucidium iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity |
| 06/05/1992 | WO1992010202A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 06/05/1992 | WO1992010199A1 Therapeutic and diagnostic applications of fetal fibronectin |
| 06/05/1992 | CA2075300A1 Therapeutic and diagnostic applications of fetal fibronectin |
| 06/04/1992 | WO1992009616A1 Enhancement of musculature in animals |
| 06/04/1992 | WO1992009613A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/04/1992 | DE4038189A1 Epididymis-specific DNA sequences |
| 06/04/1992 | DE4037809A1 Staphylococcal neutral phosphatase and 70 KD protein - isolated by immuno:affinity purificn., ion exchange chromatography or affinity chromatography and used to stimulate lymphocytes and bind immunoglobulins |
| 06/04/1992 | CA2097590A1 Enhancement of musculature in animals |
| 06/04/1992 | CA2097416A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 06/03/1992 | EP0488979A1 Novel inhibitory peptides |
| 06/03/1992 | EP0488900A1 Protein with cytokine activity, recombinant DNA, expression vector and hosts for obtaining it |
| 06/03/1992 | EP0488812A1 Non-A, non-B hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 06/03/1992 | EP0488687A2 A process for spinning polypeptide fibers |
| 06/03/1992 | EP0488622A2 Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
| 06/03/1992 | EP0488528A1 Recombinant adeno-associated virus vectors |
| 06/03/1992 | EP0488479A1 DNA sequences, recombinant DNA molecules and processes for producing swine growth hormone-like polypeptides |
| 06/03/1992 | EP0488317A2 Thrombin-binding substance and process for preparing the same |
| 06/03/1992 | EP0488279A2 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 06/03/1992 | EP0488258A2 Propenamide derivatives, polymers, copolymers and use thereof |
| 06/03/1992 | EP0488224A2 Fermentationproduct of a Verticimonosporium strain and feed additivs containing a linear peptide |
| 06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |
| 06/03/1992 | EP0488170A1 Cell-free receptor binding tests, their production and use |
| 06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
| 06/03/1992 | EP0487709A1 Dna probes and primers for detection of b. burgdorferi using the polymerase chain reaction. |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
| 06/03/1992 | EP0487618A1 Thylakoid targeting sequence |
| 06/03/1992 | EP0487617A1 Synthetic peptides that enhance cell binding. |
| 06/03/1992 | EP0487615A1 Ferritin analogs. |
| 06/03/1992 | EP0487610A1 Prohormone cleavage site blocking antibody |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | EP0474789A4 Cysteine thiol-protected peptides for use in immunoassays |
| 06/03/1992 | EP0452391A4 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 06/03/1992 | EP0202260B1 Improved antigenic preparation |
| 06/03/1992 | CN1061623A The ciliary neurotrophic factor receptor |
| 06/03/1992 | CN1061607A Identification of cell density signal molecule |
| 06/03/1992 | CN1061606A Polypeptide compounds having growth hormone releasing activity |
| 06/02/1992 | USH1065 Veternary genetic engineering |
| 06/02/1992 | US5118795 Viral inactivation by freeze drying; heating; reconstituting concentrate |
| 06/02/1992 | US5118794 Process for stabilizing human albumin solutions and the solution obtained |
| 06/02/1992 | US5118793 Substitution of arginine at position 44 for leucine; antithrombin |
| 06/02/1992 | US5118792 Ice crystal growth suppression polypeptides and method of making |
| 06/02/1992 | US5118791 Biologically active polypeptides based on transforming growth factor-β |
| 06/02/1992 | US5118790 Analogs of hirudin |
| 06/02/1992 | US5118789 Obtained from larvae injured in body wall |
| 06/02/1992 | US5118668 Peptide having sequence of appotinin where in one or more amino acids are replaced at position 15,16,17,18 34-39 and 52. by naturally occuring amino acid useful for hyperfibrinolytic or traumatic hemorrhage |
| 06/02/1992 | US5118666 Insulinotropic hormone |
| 06/02/1992 | US5118622 Polypeptide possessing isoamylase activity, and its use in the hydrolysis of amylaceous substances |
| 06/02/1992 | US5118617 Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces |
| 06/02/1992 | US5118616 Method of producing substances in living silkworms |
| 06/02/1992 | US5118615 Gene insertion to an expression vector; hypotensive and diuretic |
| 06/02/1992 | US5118614 Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| 06/02/1992 | US5118606 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products |
| 06/02/1992 | US5118602 Feline T-lymphotropic lentivirus assay |
| 06/02/1992 | US5118501 Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies |
| 06/02/1992 | CA1302652C Method for purifying granulocyte-macrophage colony stimulating factor |
| 06/02/1992 | CA1302651C Fsh-releasing peptide |
| 06/02/1992 | CA1302650C Gnrh antagonists viii |
| 06/02/1992 | CA1302320C Expression of human cromosomal interferon-_ in animal cells |
| 05/31/1992 | WO1992009631A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | WO1992009627A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor |
| 05/31/1992 | WO1992009620A1 Solution phase process for synthesis of peptide |
| 05/31/1992 | CA2097309A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2097305A1 Solution phase process for synthesis of peptide |
| 05/31/1992 | CA2074945A1 Tumor cell invasion-inhibiting peptides, peptide complexes and cancer metastasis inhibitors |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/31/1992 | CA2056564A1 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 05/30/1992 | WO1992009630A1 Imidoester cross-linked hemoglobin compositions |
| 05/30/1992 | CA2093650A1 Imidoester cross-linked hemoglobin compositions |
| 05/30/1992 | CA2056646A1 Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008797A1 Heterologous gene expression system |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008788A1 Mutant orientable proteins and coated substrates |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008740A2 Receptor recognition factor and methods of use thereof |